How to Inject a GLP-1 Pen: Sites, Rotation, and Common Mistakes

Key takeaways

• The three FDA-approved injection zones for GLP-1 pens are the abdomen, front of the thigh, and back of the upper arm — the abdomen is usually the most consistent and least painful.
• Rotate within a zone each week and switch zones every few weeks to avoid lipohypertrophy, the lumpy fatty thickening that can make doses absorb unpredictably.
• Most bruising comes from a few fixable causes: cold medication, wet alcohol, releasing the dose button too early, reusing needles, or rubbing the site after withdrawal.
• Hold the dose button for at least the number of seconds your instructions for use specify (commonly 6 seconds) so the full dose delivers before you withdraw the needle.
• Compounded semaglutide and tirzepatide are not FDA-approved as finished products, and any dose, device, or switch decision should go through a licensed prescriber.

Why injection technique matters more than the leaflet suggests

Most GLP-1 prescriptions arrive in a small refrigerated box with a pen, a stack of needle tips, and a folded instructions-for-use sheet that is technically complete but rarely enough for a first-time self-injector. The pharmacist hands it over with a sentence or two, the telehealth provider sends a short video link, and the rest is on you. That gap is where bruises, missed doses, lumpy skin, and quiet anxiety about whether you are doing it right tend to creep in.

Good technique is not just about comfort. Injection site, depth, and rotation all influence how the drug is absorbed and how steady your blood levels stay between doses. The big GLP-1 trials, including STEP-1 for (about 15% mean weight loss at 68 weeks) and SURMOUNT-1 for (about 21% at the highest dose), all assumed patients were injecting correctly into subcutaneous fat, not muscle, and rotating sites week to week. Sloppy technique will not necessarily ruin your results, but it can blunt them and make side effects worse.

This guide walks through the technique that applies across the most common pens: , , , , and daily . It is meant to fill in the practical gaps between the label and your kitchen counter. It is not medical advice. GLP1Zoom doesn't prescribe or sell medication — we compare and redirect to licensed providers — so any change to your dose, schedule, or device should still go through your prescriber.

The three approved injection zones

Every FDA-approved GLP-1 pen on the U.S. market is designed for subcutaneous injection, meaning the layer of fat that sits between your skin and your muscle. The prescribing information for Ozempic, Wegovy, Mounjaro, Zepbound, and Saxenda all name the same three zones: the abdomen, the front of the thigh, and the back of the upper arm. You should not inject into muscle, into a vein, or into broken, scarred, or actively inflamed skin.

Each zone has trade-offs. The abdomen tends to absorb medication the most consistently and is the easiest spot to reach yourself. Most patients report the lowest pain scores here, especially in the area roughly two inches away from the navel, where the fat layer is usually thick enough that the needle does not catch muscle. Avoid the area right around the belly button and any stretch-marked or surgical scar tissue.

The front of the thigh works well but has a thinner fat layer in lean patients, which raises the risk of accidentally hitting the muscle underneath. If you use the thigh, pick the upper outer quarter and pinch the skin gently. The back of the upper arm is the hardest to self-inject because you cannot see what you are doing; most patients only use it if a partner or caregiver is helping them rotate sites.

• Abdomen: most consistent absorption, easiest to self-inject, avoid 2 inches around the navel.
• Front of thigh: workable but thinner fat layer; pinch the skin if you are lean.
• Back of upper arm: low pain but hard to reach yourself; better with a helper.

How to rotate sites without overthinking it

Rotation matters because injecting into the exact same square inch over and over can cause lipohypertrophy, a lumpy thickening of the fatty tissue that has been well documented in long-term insulin users and is plausible with weekly GLP-1 use too. Lumpy tissue absorbs drug unpredictably, which can make a dose feel weaker one week and stronger the next. The fix is simple: never inject the same spot two doses in a row.

A practical rotation pattern is to imagine your chosen zone, say the abdomen, as a clock face around the navel. Inject at 12 the first week, 3 the next, 6 the next, and 9 after that, staying at least an inch from your previous spot. After a full month, shift to a different zone — for example, switch to the right thigh for the next four weeks, then the left thigh, then back to the abdomen. Some patients prefer to alternate sides each dose instead, which also works.

If you are on a daily injection like , rotation matters even more because you are puncturing skin seven times a week. The same clock-face approach scales down: just pick a fresh point each day and circle around. Keep a simple log on your phone or the pen box for the first month or two until the pattern becomes muscle memory.

Step-by-step: how to inject a weekly GLP-1 pen

The mechanics are similar across , , , and , though the specific dial and click behavior differs slightly between Novo Nordisk and Eli Lilly pens. Always follow the instructions for use that came with your specific device. The steps below are a general walkthrough, not a substitute for your prescriber or the label.

The full sequence should take about a minute once you are used to it. Most patients describe the actual injection as a brief sting or pressure rather than sharp pain, especially after the first few doses when the anticipation fades.

1. Take the pen out of the fridge 15 to 30 minutes before injecting so the liquid warms to room temperature. Cold medication stings more.
2. Wash your hands with soap and water. Choose a site within your planned rotation zone, at least an inch from your last injection.
3. Wipe the site with an alcohol swab and let it fully air-dry. Wet alcohol on the skin is a common cause of sting.
4. Attach a fresh needle tip, remove both caps, and check that the medication looks clear and colorless. Discard if cloudy or particulate.
5. Prime the pen if your specific device requires it (Ozempic and Wegovy require a flow check the first time you use a new pen; check your IFU).
6. Dial the dose your prescriber prescribed. Do not improvise doses.
7. Pinch a relaxed fold of skin if you are lean or using the thigh. Insert the needle straight in at 90 degrees in a single smooth motion.
8. Press the dose button fully and hold for at least 6 seconds (or the number of seconds your IFU specifies) so the full dose delivers.
9. Withdraw the needle straight out. Press a clean cotton ball or gauze on the spot without rubbing. Do not massage the site.
10. Recap the outer needle shield carefully, remove the needle, and dispose of it in an FDA-cleared sharps container.

Storage, temperature, and pen handling

Storage mistakes are one of the most under-discussed causes of weak or inconsistent doses. Per the FDA prescribing information, unopened Ozempic, Wegovy, Mounjaro, and Zepbound pens should be kept refrigerated between 36 and 46 degrees Fahrenheit, away from the freezer compartment and out of direct light. Once in use, the pens have specific room-temperature stability windows printed on the label — for example, Ozempic and Wegovy can typically be kept at room temperature up to 86 degrees Fahrenheit for a defined number of days after first use. Always confirm the exact window on your current pen's IFU.

Never use a pen that has been frozen, even briefly. Freezing can damage the peptide and you cannot tell visually whether it still works. If you suspect your shipment got too cold or too hot in transit, call the pharmacy before injecting. Compounded GLP-1 vials, which are not FDA-approved as finished products, often have different and sometimes stricter storage rules — read the pharmacy's instructions carefully.

Each needle tip is single-use. Reusing needles dulls the tip, raises the risk of contamination, and is a leading cause of bruising and skin reactions. Keep a sharps container nearby so the friction of finding one does not tempt you to skip a step. Most U.S. pharmacies will accept full sharps containers for disposal, and many municipalities offer free mail-back programs.

The mistakes that cause bruising, lumps, and weak doses

Bruising, stinging, and lumpy skin are almost always traceable to a small handful of technique errors, not to the medication itself. Identifying which one is happening to you is usually enough to fix it. If a problem persists after you correct your technique, that is the signal to call your prescriber rather than tough it out.

One subtle mistake worth flagging: some patients try to reduce nausea by under-dosing themselves — dialing less than what was prescribed, or skipping doses. This is a treatment decision, not a technique decision, and it should go through your clinician. The trial data for STEP-1, SURMOUNT-1, SUSTAIN, and SCALE all assume patients followed the prescribed titration schedule.

• Releasing the dose button too early: holding for fewer seconds than the IFU specifies means part of your dose stays inside the pen.
• Injecting cold medication straight from the fridge: the cold liquid stings and bruises more. Let it warm for 15 to 30 minutes.
• Injecting through wet alcohol: alcohol that has not fully evaporated dramatically increases sting.
• Skipping rotation: repeatedly hitting the same spot causes lipohypertrophy and unpredictable absorption.
• Reusing needles: dulled tips tear tissue, raising bruise and infection risk.
• Injecting too close to a vein, scar, mole, or stretch mark: any of these can trap the needle path and cause bleeding.
• Rubbing the site after injection: rubbing pushes medication out of the subcutaneous space and increases bruising. Press, do not rub.
• Storing the pen in a door shelf of the fridge: the door fluctuates in temperature; use a middle shelf instead.

How technique differs across the major pens

The high-level technique is similar across brands, but the device mechanics are different enough that you should not assume your old habits transfer when you switch. Novo Nordisk pens (, , ) use NovoFine or NovoTwist needle tips that you screw on for each dose. Eli Lilly pens (, ) are sold as single-dose autoinjectors with the needle hidden inside, so you do not see or attach the needle yourself.

With a hidden-needle autoinjector like the Mounjaro or Zepbound KwikPen-style device, you place the base flat against your skin, press, and listen for the clicks that confirm the dose has fully delivered. The trade-off is convenience and less needle anxiety, but you have less feedback about exactly when the needle enters and exits. With a screw-on-needle pen like Ozempic or Wegovy, you have more control and visibility but more steps.

Saxenda is the outlier as a daily liraglutide pen rather than a weekly. The injection mechanics are similar to Ozempic and Wegovy, but you will be puncturing skin every day, which makes rotation discipline and storage routine even more important. If you are switching between brands — for example, from Ozempic to Mounjaro, or Saxenda to Wegovy — ask the pharmacist for a fresh device walkthrough rather than guessing.

When to stop and call your prescriber

Most injection problems are cosmetic and self-correcting. A small bruise, a brief sting, or a tiny bead of blood after withdrawal are normal and do not require a call. But there are a few patterns where you should stop injecting and contact a clinician rather than waiting until your next refill.

These are the situations where the issue has likely moved beyond technique. Severe or unusual reactions can also indicate a hypersensitivity to the medication itself, which is rare but documented in the labels for semaglutide, tirzepatide, and liraglutide.

• A firm lump under the skin that does not fade within a week, especially if it is growing.
• Redness, warmth, swelling, or pus at a site, which can signal infection.
• A bruise that keeps spreading after 48 hours or is unusually large.
• Severe pain during or after injection that does not resolve within minutes.
• Hives, throat tightness, difficulty breathing, or facial swelling — call emergency services first.
• Persistent severe nausea, vomiting, or upper abdominal pain after a dose, which the FDA labels flag as warning signs that need medical attention.
• Suspected freezing or overheating of your pen during shipment or storage.

A note on compounded GLP-1 vials

A meaningful share of telehealth GLP-1 prescriptions in the U.S. are compounded semaglutide or tirzepatide drawn from vials with a syringe, not pre-filled pens. Compounded medications are not FDA-approved as finished products. They are made by licensed compounding pharmacies under different oversight rules than branded pens like Ozempic, Wegovy, Mounjaro, or Zepbound, and the FDA has issued multiple advisories about dosing errors and sterility concerns with this category.

If you are injecting from a vial, the technique principles in this guide still apply — same three zones, same rotation logic, same hold time, same storage discipline — but the mechanics differ. You will be drawing up a dose with a syringe, which introduces measurement risk that pen users do not face. Dose every unit on the syringe according to your prescriber's written instructions, double-check before injecting, and never improvise.

If your dosing instructions are unclear, the vial looks cloudy, or you receive a different concentration than your previous shipment, do not inject. Call the prescribing telehealth provider and the compounding pharmacy before your next dose. Switching between a compounded vial and a branded pen, or between concentrations, is a clinical decision that belongs with your prescriber.

Frequently asked questions

Where is the least painful place to inject a GLP-1 pen?

Most patients report the lowest pain scores in the abdomen, roughly two inches away from the navel, because the subcutaneous fat layer there is thicker and the area contains fewer surface nerves than the thigh. The back of the upper arm is also low-pain but harder to reach yourself. Letting the pen warm to room temperature for 15 to 30 minutes, pinching a relaxed fold of skin, and inserting the needle quickly at 90 degrees further reduce sting. If a specific site stays painful for more than a day, rotate away from it and tell your prescriber.

Do I need to pinch my skin when injecting Ozempic or Wegovy?

Novo Nordisk's instructions for use for Ozempic and Wegovy do not require a skin pinch because the pen needles are short (typically 8mm or less) and designed to land in subcutaneous tissue at 90 degrees. However, very lean patients, people injecting the thigh, or anyone using a longer needle often benefit from a gentle pinch to lift fat away from muscle. Pinch with your thumb and index finger only, not your whole hand, so you do not bunch up muscle tissue underneath.

What happens if I inject a GLP-1 into muscle by accident?

Accidentally injecting into muscle, called intramuscular injection, usually causes more pain, faster drug absorption, and a higher chance of bruising or a small hematoma. For most people there is no long-term harm, but the faster absorption can intensify side effects like nausea for that dose. To avoid it, pinch the skin if you are lean, use the abdomen or back-of-arm rather than the thigh when possible, and do not inject directly over a visible muscle while it is flexed.

Why am I bruising every time I inject my GLP-1 pen?

Bruising usually points to one of four issues: holding the needle in for less than the 6 seconds the label specifies, injecting too close to a surface vein, reusing or bending needles, or being on a blood thinner or fish oil that increases bleeding. Try a fresh needle each dose, pick a site without visible veins, press a clean cotton ball gently after withdrawal without rubbing, and review any anticoagulants or supplements with your prescriber. Persistent or large bruises deserve a clinical check.

Can I inject my GLP-1 in the same spot every week?

You should not. Repeatedly injecting the same square inch raises the risk of lipohypertrophy, which is a lumpy fatty thickening under the skin that can blunt absorption and make doses feel less effective. The general guidance is to rotate within an injection zone each week and switch zones every few weeks, while staying at least an inch away from your previous site. If you notice a firm lump that does not fade, stop injecting that spot and ask a clinician to examine it.

What time of day is best for my GLP-1 injection?

There is no clinically required time of day for weekly GLP-1 pens like Ozempic, Wegovy, Mounjaro, or Zepbound because their half-lives are long enough that timing within a 24-hour window does not meaningfully change drug levels. What matters most is picking a day and time you will remember consistently. Many patients prefer evenings so that peak nausea, if it occurs, happens during sleep, but morning injections work equally well. Daily Saxenda is typically dosed at the same time each day per its label.

Is it safe to inject through clothing or a tattoo?

Injecting through clothing is not recommended because fabric can carry skin bacteria into the puncture site, dull the needle, and prevent you from seeing whether you hit a vein or scar. Injecting directly over a tattoo is also discouraged in the short term while the tattoo is healing, and longer-term because the ink layer changes how subcutaneous tissue absorbs medication and can mask early signs of a site reaction. Choose clean, intact, non-tattooed skin whenever possible.